Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Ralph F. Hirschmann is active.

Publication


Featured researches published by Ralph F. Hirschmann.


Life Sciences | 1984

A super active cyclic hexapeptide analog of somatostatin

Daniel F. Veber; Richard Saperstein; Ruth F. Nutt; Roger M. Freidinger; Stephen F. Brady; Paul E. Curley; Debra S. Perlow; William J. Paleveda; C. Dylion Colton; Anthony G. Zacchei; Dominick J. Tocco; Dale Richard Hoff; Richard L. Vandlen; J. E. Gerich; L. D. Hall; Lawrence J. Mandarino; Eugene H. Cordes; Paul S. Anderson; Ralph F. Hirschmann

The cyclic hexapeptide, cyclo (Pro-Phe-D-Trp-Lys-Thr-Phe), I, has been shown to have the biological properties of somatostatin. We now report structure-activity studies which optimize the potency of this cyclic hexapeptide series with the synthesis of cyclo (N-Me-Ala-Tyr-D-Trp-Lys-Val-Phe), II, which is 50-100 times more potent than somatostatin for the inhibition of insulin, glucagon and growth hormone release. The hydroxyl group of tyrosine is seen to lend a 10-fold enhancement to the potency. Potency also is found to be correlated with hydrophobicity. II is found to improve the control of postprandial hyperglycemia in diabetic animals when given in combination with insulin. The analog is found to be quite stable in the blood and in the gastrointestinal tract, but the bioavailability after oral administration is only 1-3%. The biological properties and long duration of II should allow clinical evaluation of the inhibition of glucagon release as an adjunct to insulin in the treatment of patients with diabetes.


Biochemical and Biophysical Research Communications | 1971

Synthesis of a proposed growth hormone releasing factor.

Daniel F. Veber; Carl D. Bennett; John D. Milkowski; George Gal; Robert G. Denkewalter; Ralph F. Hirschmann

Abstract The synthesis of Val-His-Leu-Ser-Ala-Glu-Glu-Lys-Glu-Ala, isolated by Schally, et al. from porcine hypothalamus and reported by him to possess growth hormone releasing activity, is described. Similarities between this decapeptide and the amino-terminal sequence of the β-chain of porcine hemoglobin are pointed out. The syntheses of two analogs including the amino-terminal decapeptide of the β-chain of human hemoglobin are also described.


Archive | 1973

Tactics for Minimal Protection in Peptide Synthesis

Ralph F. Hirschmann; Daniel F. Veber

Viel allgemeinerer Anwendung fahig ist, wie wir im folgenden zeigen, der Rest C6H5·CH2·O·CO der Benzylester-kohlensaure, kurz Carbobenzoxy-Rest (Cbzo) gennant; denn er lasst sich mit Hilfe des leicht zuganglichen Chlorids C6H5·CH2O·CO·Cl unschwer in Amino-sauren der verschiedensten Art einfuhren… und—was das Wesentliche ist—durch einfache katalytische Hydrierung im offenen Gefass in Form von Toluol und Kohlendioxyd wieder abspalten. (Max Bergmann and Leonidas Zervas, Chem. Ber. 65:1192, 1932)


Archive | 1983

Indacrinone having enhanced uricosuric

Edward H. Blaine; Edward J. Cragoe; Ralph F. Hirschmann; John F. Nancarrow; Elisabeth M. Nancarrow executrix by; Jonathan A. Tobert


International Journal of Peptide and Protein Research | 2009

Somatostatin analogs which define the role of the lysine‐9 amino group

Ruth F. Nutt; Daniel F. Veber; Paul E. Curley; Richard Saperstein; Ralph F. Hirschmann


International Journal of Peptide and Protein Research | 2009

Lactam restriction of peptide conformation in cyclic hexapeptides which alter rumen fermentation.

Roger M. Freidinger; Daniel F. Veber; Ralph F. Hirschmann; Lynn M. Paege


Archive | 1971

PROCESS FOR CONTROLLED STEPWISE SYNTHESIS OF POLYPEPTIDES

Ralph F. Hirschmann; Robert G. Denkewalter


Biochemistry | 1978

Dihydrofolate reductase: the amino acid sequence of the enzyme from a methotrexate-resistant mutant of Escherichia coli.

Carl D. Bennett; John A. Rodkey; John M. Sondey; Ralph F. Hirschmann


Archive | 1959

Antihemorrhagic compounds and processes for preparing the same

Ralph F. Hirschmann


Archive | 1976

PYRIDYL-4-METHYL-SUCCINIMIDOCARBONATE AND PROCESS FOR ITS PREPARATION

Ralph F. Hirschmann; Daniel F. Veber

Researchain Logo
Decentralizing Knowledge